CMTx Biotech
Joseph Scaduto is the Co-Founder & CEO at CMTx Biotech. Previously, Joseph was Director of Business Development at PreSight Technologies, Inc. Joseph holds a MBA Finance from Stony Brook University.
This person is not in any offices
CMTx Biotech
CMTx Biotech is a clinical-stage biopharmaceutical company that is developing an orally administered small molecule for the treatment of sepsis patients at risk of Acute Respiratory Distress Syndrome (ARDS) and/or Multiple Organ Dysfunction Syndrome (MODS), including those infected with SARS-CoV-2 (COVID-19).